论文部分内容阅读
分别应用潘托拉唑、兰索拉唑及雷尼替丁治疗十二指肠球部溃疡,并对其疗效进行观察。1 资料与方法1.1 临床资料选择经胃镜确诊的活动性十二指肠球部溃疡患者136例,男性86例,女性50例;年龄(40±5)岁,病程(6±3)年。溃疡直径0.2cm-2.5cm,其中单发90例,多发46例。按病程单发或多发及溃疡大小随机分为3组,甲组为潘托拉唑治疗组(46例);乙组为兰索拉唑治疗组(45例);丙组为雷尼替丁治疗组(45例)1.2 治疗方法甲组每日早、晚各服潘托拉唑40mg;乙组每日早、晚各服兰索拉唑30mg;丙组每日早、晚各服雷尼替丁150mg 疗程均为4周,治疗过程中均不用其它制酸剂及止痛剂
Respectively use of pantoprazole, lansoprazole and ranitidine treatment of duodenal ulcer, and its efficacy were observed. 1 Materials and Methods 1.1 Clinical data selected 136 cases of active duodenal ulcer patients diagnosed by endoscopy, 86 males and 50 females; aged (40 ± 5) years, duration of (6 ± 3) years. Ulcer 0.2cm-2.5cm in diameter, of which 90 cases were single, multiple in 46 cases. According to the duration of single or multiple and ulcer size were randomly divided into three groups, a group of pantoprazole treatment group (46 cases); B group lansoprazole treatment group (45 cases); C group of ranitidine Treatment group (45 cases) 1.2 Treatment Group A daily morning and evening pantoprazole 40mg; Group B daily morning and evening lansoprazole 30mg; Group C daily morning and evening service Renai Ding for 150mg course of treatment are 4 weeks, no other antacids and analgesics during the treatment